Diagnosis of Dengue by NS1 Detection: Comparison of Rapid Immunochromatography versus ELISA Kits
Parole chiave:
Dengue, Dengue hemorrhagic fever, NS1Ag, IgG, IgMAbstract
Dengue is an acute infectious disease of viral etiology. It is probably one of the most important arthropod borne viral disease in terms of human morbidity and mortality. The spectrum of disease ranges from self-limited dengue fever to more severe forms of dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). So, to reduce mortality and morbidity early and accurate diagnosis of dengue is essential. Study assessed comparison of currently available rapid test for NS1, IgG, and IgM combo kit and conventional dengue Ag ELISA test (CTK Biotech) ELISA kit. The performance of rapid kit RICT (Dengue Day 1 Test; J. Mitra) is quite satisfactory as sensitivity of test as compared to ELISA test was 94.44%. Regarding specificity, with reference to dengue Ag ELISA test (CTK Biotech), the specificity of RICT (Dengue Day 1 test; J. Mitra) was 71.43%. The use of combination kit helps to detect additional cases of dengue, which are negative for NS1 antigen but positive for IgM and/or IgG antibodies, thus facilitating early diagnosis in remote areas and small laboratories. Keywords: Dengue, NS1, ELISA, immunochromatography Cite this Article Gaurav Saraf, Vasudev Patidar, Asha Sharma, Pushpa Mehta. Diagnosis of Dengue by NS1 Detection: Comparison of Rapid Immunochromatography versus ELISA Kits. Research & Reviews: Journal of Microbiology and Virology. 2016; 6(2): 18–22p.Pubblicato
Fascicolo
Sezione
Licenza
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |